BRIEF-Molecular Partners presents preliminary results from the ongoing phase 2 study of MP0250

BRIEF-Molecular Partners presents preliminary results from the ongoing phase 2 study of MP0250

April 23 (Reuters) – Molecular Partners AG:

* Said on Saturday had presented preliminary results from the ongoing phase 2 study of MP0250 at the European Myeloma Network Meeting in Turin

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Source Article